(Q86654387)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Nivolumab in a patient with refractory Hodgkin's lymphoma after allogeneic stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Arik Bernard Schulze

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Torsten Kessler

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

L Angenendt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C Schliemann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

E Rebber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Weckesser

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

L Stegger

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Schäfers

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C Groth

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

G Lenz

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Stelljes

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

W E Berdel

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

9 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

443-445

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26551782%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2015.266

29 February 2020

exact match

0 references

cites work

Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer.

1 reference

12 December 2020

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

12 December 2020

Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation

1 reference

12 December 2020

1 reference

12 December 2020

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.

1 reference

12 December 2020

Immune checkpoint blockade in hematologic malignancies

1 reference

12 December 2020

Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!

1 reference

12 December 2020

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma

1 reference

12 December 2020

Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients

1 reference

12 December 2020

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

1 reference

12 December 2020

Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality

1 reference

12 December 2020

Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography

1 reference

12 December 2020

Hodgkin's lymphoma in adults

1 reference

12 December 2020

Immune therapy of metastatic melanoma developing after allogeneic bone marrow transplant

1 reference

12 December 2020